Pulmonx Corp (LUNG) Stock Price, Quote & News

Company Profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography a...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 364 0400

Website: pulmonx.com

Address:

700 Chesapeake Drive, Redwood City, United States

StMichaelTwits Jan. 13 at 2:24 PM

$LUNG This might be the best time to buy this stock under $2 Insiders are buying. I am trying to get greedy buying near the 1.90 if I can get those.. Timeline for AeriSeal (NCT04044807) Based on the most recent updates in the clinical database: Primary Completion Date: Currently estimated for May 2026. Study Completion Date: Estimated for December 2026. Accumulation phase is happening imo The "Data Run" (April - May 2026): Expect the volume to pick up as the Primary Completion date approaches. Traders will start betting on a positive outcome.👈 I expect $3.50 by this time line of end of April 👈 imo The "Catalyst Event" (Summer 2026): Once the data is analyzed (usually 4–8 weeks after the May completion), Pulmonx will issue a Press Release. Approval could get this over $7+

1 · Reply

beachsidefreddy Jan. 12 at 5:47 PM

$LUNG Michael think that was bottom

2 · Reply

beachsidefreddy Jan. 12 at 5:16 PM

$LUNG 5000 at 1.985

0 · Reply

beachsidefreddy Jan. 12 at 4:41 PM

$LUNG I knew this would not stay down

0 · Reply

beachsidefreddy Jan. 12 at 3:00 PM

$LUNG their RSU ARE UNDER WATER can’t stay here

0 · Reply

PSM_EmpowerTrading Jan. 12 at 2:25 PM

🌅 Watchlist part 2 ✅ $BARK low $0.70 support, if above $1.00, potential to $1.20 / $1.40 ✅ $ZNTL $3.80 support, if above $4.00, potential to $4.50 / $4.70 ✅ $CGTL low $2.60 support, if above $2.80, potential to $3.00 / $3.40 🚨 Not ideal for swing accumulation at current prices ✅ Ideal long entry near low current support 🎯 Ideal stop loss below current support 🚨 Avoid chasing long into strength near resistance ⏳⏳ $LUNG $YCBD still in swing accumulation phase 🎯🎯 Goal is GR💰💰N, not GR🔥🔥D

1 · Reply

beachsidefreddy Jan. 12 at 1:14 PM

$LUNG https://www.fda.gov/news-events/press-announcements/fda-increases-flexibility-requirements-cell-and-gene-therapies-advance-innovation

1 · Reply

PSM_EmpowerTrading Jan. 12 at 2:29 AM

🌅 Watchlist ✅ $BARK low $0.70 support, if above $1.00, potential to $1.20 / $1.40 ✅ $ZNTL low $4.00 support, if above $4.65, potential to $5.00 / $5.50 ✅ $CGTL low $3.00 support, if above $3.30, potential to $3.60 / $3.80 🚨 The above tickers are not ideal for swing accumulation at current prices ✅ Ideal long entry near current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳ $LUNG $YCBD still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D

0 · Reply

StMichaelTwits Jan. 9 at 9:03 PM

$LUNG I think being above 2 on the close, was critical. I think this was bottom.

0 · Reply

PSM_EmpowerTrading Jan. 9 at 8:18 PM

⌛️⏳️Potential swing ideas 💡 ✅️ $IKT company focuses on developing therapies for neurodegenerative disorders, especially Parkinson's disease and related conditions, upcoming catalyst: phase 3 study for Pulmonary arterial hypertension expected to begin Q1 2026, HC Wainwright price target 8, Cantor Fitzgeral price target 4 ✅️ $LUNG company focuses on minimally invasive treatments for chronic obstructive pulmonary disease (COPD) and severe emphysema, D. Boral Capital price target $14, Stifel Nicolaus buy rating, Lake Street price target 4, Canaccord Genuity buy rating ✅️ $XELB company focuses on medica and consumer products, designing, licensing, marketing and selling branded products, band portfolio includes Halston, Judity Ripka, C Wonder, TowerHill by Christie Brinkley, Longaberger and others across apparel, footwear, accessories, home goods, CEO Robert D'Loren and Director Mark DiSanto recently purchased shares, Noble Financial buy rating

1 · Reply

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Nov 12, 2025, 7:21 PM EST - 2 months ago

Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 4:05 PM EST - 2 months ago

Pulmonx Reports Third Quarter 2025 Financial Results

Oct 27, 2025, 4:05 PM EDT - 2 months ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Oct 15, 2025, 4:05 PM EDT - 3 months ago

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

Aug 26, 2025, 4:05 PM EDT - 5 months ago

Pulmonx to Participate in September Investor Conferences

Jul 30, 2025, 10:00 PM EDT - 5 months ago

Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 5 months ago

Pulmonx Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 4:05 PM EDT - 6 months ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

May 28, 2025, 4:05 PM EDT - 8 months ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

May 1, 2025, 4:05 PM EDT - 9 months ago

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Apr 30, 2025, 8:25 PM EDT - 9 months ago

Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 9 months ago

Pulmonx Reports First Quarter 2025 Financial Results

Mar 3, 2025, 7:00 AM EST - 11 months ago

EDAP Appoints Glen French to Board of Directors

EDAP

Feb 20, 2025, 3:50 PM EST - 11 months ago

Top 3 Health Care Stocks You May Want To Dump In February

MD SWTX

Feb 19, 2025, 7:40 PM EST - 11 months ago

Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 4:05 PM EST - 11 months ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 13, 2025, 4:05 PM EST - 11 months ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Feb 5, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Nov 20, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 9:00 AM EST - 1 year ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 5, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Oct 31, 2024, 6:54 AM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Oct 16, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Sep 9, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 22, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Jul 31, 2024, 10:33 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 21, 2024, 9:00 AM EDT - 1 year ago

Pulmonx: Low Bar For Q2 Earnings

Jul 10, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

May 1, 2024, 9:08 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

May 1, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Reports First Quarter 2024 Financial Results

Apr 10, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 2, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Feb 26, 2024, 8:00 AM EST - 2 years ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 21, 2024, 9:01 PM EST - 2 years ago

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 4:06 PM EST - 2 years ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:05 PM EST - 2 years ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 7, 2024, 4:05 PM EST - 2 years ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Nov 15, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 8, 2023, 12:01 PM EST - 2 years ago

The Prognosis For Pulmonx Corporation

Oct 31, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Participate at Upcoming Investor Conferences

Oct 30, 2023, 8:37 PM EDT - 2 years ago

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 16, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 10, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Aug 6, 2023, 2:20 AM EDT - 2 years ago

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Second Quarter 2023 Financial Results

StMichaelTwits Jan. 13 at 2:24 PM

1 · Reply

beachsidefreddy Jan. 12 at 5:47 PM

$LUNG Michael think that was bottom

2 · Reply

beachsidefreddy Jan. 12 at 5:16 PM

$LUNG 5000 at 1.985

0 · Reply

beachsidefreddy Jan. 12 at 4:41 PM

$LUNG I knew this would not stay down

0 · Reply

beachsidefreddy Jan. 12 at 3:00 PM

$LUNG their RSU ARE UNDER WATER can’t stay here

0 · Reply

PSM_EmpowerTrading Jan. 12 at 2:25 PM

1 · Reply

beachsidefreddy Jan. 12 at 1:14 PM

$LUNG https://www.fda.gov/news-events/press-announcements/fda-increases-flexibility-requirements-cell-and-gene-therapies-advance-innovation

1 · Reply

PSM_EmpowerTrading Jan. 12 at 2:29 AM

0 · Reply

StMichaelTwits Jan. 9 at 9:03 PM

$LUNG I think being above 2 on the close, was critical. I think this was bottom.

0 · Reply

PSM_EmpowerTrading Jan. 9 at 8:18 PM

1 · Reply

sk7777777 Jan. 9 at 5:02 PM

$LUNG Yuge

0 · Reply

beachsidefreddy Jan. 9 at 5:00 PM

$LUNG AERISEAL NEWS COULD BE HUGE

0 · Reply

StMichaelTwits Jan. 9 at 3:32 PM

$LUNG At the JP Morgan conference this past week, Lung had no news and predicts same sales target for the this and last Q. Insiders are buying at these levels. Lung trading below cash. Chart shows dip after it broke 2.08. Need to find support and consolidate. Cheap down here.

5 · Reply

sk7777777 Jan. 9 at 3:17 PM

$LUNG …

0 · Reply

PSM_EmpowerTrading Jan. 9 at 2:26 PM

🌅 Watchlist part 3 ✅ $BLNE low 2.00 support; if above 2.20, has potential to 2.50 / 2.60 ✅ $LDI mid 2.60 support; if above 3.00, has potential to 3.30 / 3.50 ✅ $WHLR low 2.00 support; if above 2.40, has potential to 2.70 / 2.80 🚨 The above tickers are not ideal for swing accumulation at current prices ✅ Ideal long entry near current support 🎯 Ideal stop loss if price breaks below support 🚨 Avoid chasing into strength near resistance ⏳ $LUNG, $HOUR still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D

0 · Reply

PSM_EmpowerTrading Jan. 9 at 4:00 AM

🌅 Watchlist part 3 ✅ $OPAD low $2.00 support, if above $2.50, potential to $2.80 / $3.30 ✅ $WHLR low $2.00 support, if above $2.40, potential to $2.70 / $2.80 🚨 The above tickers are not ideal for swing accumulation at current prices ✅ Ideal long entry near current support 🎯 Ideal stop loss if below current support 🚨 Avoid chasing long into strength near resistance ⏳ $LUNG $HOUR still in swing accumulation phase 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D

2 · Reply

beachsidefreddy Jan. 8 at 8:35 PM

$LUNG they were climbing all over each other to pay 2.36 two days ago

1 · Reply

StMichaelTwits Jan. 8 at 5:32 PM

$LUNG Very bullish on this company. Slow mover for now. 👇😘

1 · Reply

StMichaelTwits Jan. 8 at 5:03 PM

$LUNG here is my 2.11 but dang, I just bought this morning VRCA for the pdufa play. On watch i might be able to get a few..

0 · Reply

beachsidefreddy Jan. 7 at 7:16 PM

$LUNG they want 2.21 stock big time

0 · Reply

beachsidefreddy Jan. 7 at 3:31 PM

$LUNG scam they do every day!!! Try to weed weak

1 · Reply

healthcareguru Jan. 6 at 5:25 PM

$LUNG no clue why these weakhanded, punkass penny flippers are here and trying to take profits on $0.05 moves…focus on Tens of DOLLARS. Top SMID-Cap Pick; Turnaround underway; stupid cheap valuation. $15 PT.

1 · Reply

Market Cap	82.08M
Revenue (ttm)	83.79M
Net Income (ttm)	-56.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-67.30%
Debt to Equity Ratio	0.62

Volume	297,400
Avg Vol	952,108
Day's Range	N/A - N/A
Shares Out	41.25M
Stochastic %K	6%
Beta	0.10
Analysts	Strong Sell
Price Target	$5.75